How to buy Actinogen Medical shares

Actinogen Medical Limited is a biotechnology business based in Australia. Actinogen Medical shares (ACW) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Actinogen Medical has a trailing 12-month revenue of around $3.5 million.

How to buy shares in Actinogen Medical

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for Actinogen Medical. Find the share by name or ticker symbol: ACW. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Actinogen Medical reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $N/A, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of Actinogen Medical. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Actinogen Medical share price

Use our graph to track the performance of ACW stocks over time.

Actinogen Medical shares at a glance

• Key figures

Information last updated 2020-09-25.

52-week range	AUDA$0.015 - AUDA$0.0565
50-day moving average	AUDA$0.026
200-day moving average	AUDA$0.0226
Target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	AUDA$-0.009

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Actinogen Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Actinogen Medical Limited by TradingView

Actinogen Medical financials

Revenue TTM	$3.5 million
Gross profit TTM	$3.5 million
Return on assets TTM	-23.95%
Return on equity TTM	-40.15%
Profit margin	-151.59%
Book value	0.01
Market capitalisation	$29 million

TTM: trailing 12 months

Actinogen Medical share dividends

We're not expecting Actinogen Medical to pay a dividend over the next 12 months.

Have Actinogen Medical's shares ever split?

Actinogen Medical's shares were split on a 1:2 basis on 2 December 2013. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Actinogen Medical shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for Actinogen Medical shares which in turn could have impacted Actinogen Medical's share price.

Actinogen Medical share price volatility

Over the last 12 months, Actinogen Medical's shares have ranged in value from as little as $0.015 up to $0.0565. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Actinogen Medical's is 2.3536. This would suggest that Actinogen Medical's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Actinogen Medical overview

Actinogen Medical Limited, a biotechnology company, develops therapies for cognitive impairment associated with chronic neurological, psychiatric, and metabolic diseases in Australia. The company is developing Xanamem, a therapy for Alzheimer's disease, and cognitive impairment associated with schizophrenia, diabetes, and other disorders; and XanADu, which has completed Phase II clinical trials is a double-blind, randomized, and placebo-controlled study to assess the safety, tolerability, and efficacy of Xanamem in subjects with mild Alzheimer's disease. It is also developing XanaHES, a single blinded, central reader blinded, placebo-controlled, and dose escalation study of Xanamem to assess safety and tolerability in healthy elderly subjects. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is headquartered in Sydney, Australia.

Frequently asked questions

• What percentage of Actinogen Medical is owned by insiders or institutions?

  Currently 19.442% of Actinogen Medical shares are held by insiders and 19.458% by institutions.

• When does the fiscal year end for Actinogen Medical?

  Actinogen Medical's fiscal year ends in June.

• Where is Actinogen Medical based?

  Actinogen Medical's address is: 109 Pitt Street, Sydney, NSW, Australia, 2000

• What is Actinogen Medical's ISIN number?

  Actinogen Medical's international securities identification number is: AU000000ACW3